Cited by 13Psychosomatic Disorders and Their TreatmentsAnxiety, Depression, Psychometrics, Treatment, Cognitive ProcessesTreatment of Major Depression

Unveiling the interoception impairment in various major depressive disorder stages

Open access
Zhou, Hongliang, Liu, Jikang, Wu, Yuqing, Huang, Zixuan, Wang, Wenliang, Ma, Yuhang, Zhu, Haohao, Zhou, Zhenhe +2 more·2024·CNS Neuroscience & Therapeutics

Abstract

Background: The intricate pathophysiological mechanisms of major depressive disorder (MDD) necessitate the development of comprehensive early indicators that reflect the complex interplay of emotional, physical, and cognitive factors. Despite its potential to fulfill these criteria, interoception remains underexplored in MDD. This study aimed to evaluate the potential of interoception in transforming MDD's clinical practices by examining interoception deficits across various MDD stages and analyzing their complex associations with the spectrum of depressive symptoms. Methods: This study included 431 healthy individuals, 206 subclinical depression individuals, and 483 MDD patients. Depressive symptoms and interoception function were assessed using the PHQ‐9 and MAIA‐2, respectively. Results: Interoception dysfunction occurred in the preclinical phase of MDD and further impaired in the clinical stage. Antidepressant therapies showed limited efficacy in improving interoception and might damage some dimensions. Interoceptive dimensions might predict depressive symptoms, primarily enhancing negative thinking patterns. The predictive model based on interoception was built with random split verification and demonstrated good discrimination and predictive performance in identifying MDD. Conclusions: Early alterations in the preclinical stage, multivariate associations with depressive symptoms, and good discrimination and predictive performance highlight the importance of interoception in MDD management, pointing to a paradigm shift in diagnostic and therapeutic approaches.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/cns.14923

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Antidepressants demonstrate limited benefits for some components of interoceptive sensitivity while adversely influencing other interoceptive processes.

    “Further evidence suggests that antidepressants demonstrate limited benefits for some components of interoceptive sensitivity (e.g., decreased distraction of bodily signals) while adversely influencing other interoceptive processes (e.g., self-regulation and body listening) [18].”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Zhou, H., Liu, J., Wu, Y., Huang, Z., Wang, W., Ma, Y., Zhu, H., Zhou, Z., Wang, J., & Jiang, C.
Affiliations
  • Wuxi Fourth People's Hospital (CN)
  • Nanjing Medical University (CN)
  • Jiangnan University (CN)
  • Zhongda Hospital Southeast University (CN)
Corresponding author
Zhou, Hongliang
Venue
CNS Neuroscience & Therapeutics
Publisher
Wiley
Published
2024-08
Volume
30
Issue
8
Pages
e14923-e14923
ISSN
  • 1755-5930 (ISSN-L)
  • 1755-5949
OpenAlex
W4401673368
Cited by
13
References
80
Citations by year
2026: 5 · 2025: 7 · 2024: 1
FWCI
3.80
Type
journal article
Language
en
Open access
Locations
  • CNS Neuroscience & Therapeutics (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Psychosomatic Disorders and Their Treatments
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
interoception, major depressive disorder, subthreshold depression, depressive symptoms, depression prediction, MAIA-2, PHQ-9
MeSH terms
Adult, Major Depressive Disorder, Female, Humans, Male, Middle Aged, Young Adult, Interoception

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review